Strategies for multivessel revascularization in patients with diabetes

Michael E Farkouh, Michael Domanski, Lynn A Sleeper, Flora S Siami, George Dangas, Michael Mack, May Yang, David J Cohen, Yves Rosenberg, Scott D Solomon, Akshay S Desai, Bernard J Gersh, Elizabeth A Magnuson, Alexandra Lansky, Robin Boineau, Jesse Weinberger, Krishnan Ramanathan, J Eduardo Sousa, Jamie Rankin, Balram BhargavaJohn Buse, Whady Hueb, Craig R Smith, Victoria Muratov, Sameer Bansilal, Spencer King, Michel Bertrand, Valentin Fuster, FREEDOM Trial Investigators, Marcus Flather

Research output: Contribution to journalArticlepeer-review

1506 Citations (Scopus)


In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease.
Original languageEnglish
Pages (from-to)2375-2384
Number of pages10
JournalNew England Journal of Medicine
Issue number25
Publication statusPublished - 20 Dec 2012


  • Humans
  • Stroke
  • Aged
  • Angioplasty, Balloon, Coronary
  • Kaplan-Meier Estimate
  • Coronary Artery Bypass
  • Cardiovascular Diseases
  • Middle Aged
  • Drug-Eluting Stents
  • Myocardial Infarction
  • Coronary Artery Disease
  • Diabetes Complications
  • Female
  • Male

Cite this